All In MedTech

FDA Clearance Tracker · P990020-S009

THE ANEURX STENT GRAFT WITH XPEDIENT DELIVERY SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 21, 2002 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 21, 2002

Approved

Time to decision

171 days

Received Jun 3, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990020-S009
Device name
THE ANEURX STENT GRAFT WITH XPEDIENT DELIVERY SYSTEM
Applicant location
Santa Rosa, CA
Received
Jun 3, 2002
Decided
Nov 21, 2002
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P990020

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE XPEDIENT DELIVERY SYSTEM. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME ANEURX STENT GRAFT WITH EXPEDIENT DELIVERY SYSTEM AND IS INDICATED FOR THE ENDOVASCULAR TREATMENT OF INFRARENAL ABDOMINAL AORTIC OR AORTO-ILIAC ANEURYSMS HAVING: 1) INFRARENAL, NON-ANEURYSMAL, NECK LENGTH OF GREATER THAN 1 CM AT THE PROXIMAL AND DISTAL ENDS OF THE ANEURYSM AND AN INNER VESSEL DIAMETER APPROXIMATELY 10-20% SMALLER THAN THE LABELED DEVICE DIAMETER: 2) MORPHOLOGY SUITABLE FOR ENDOVASCULAR REPAIR; 3) ONE OF THE FOLLOWING: A) ANEURYSM DIAMETER > 5 CM; B) ANEURYSM DIAMETER OF 4-5 CM WHICH HAS ALSO INCREASED IN SIZE BY 0.5 CM IN THE LAST 6 MONTHS; OR C) ANEURYSM WHICH IS TWICE THE DIAMETER OF THE NORMAL INFRARENAL AORTA.

Source documents

Other decisions for Medtronic Vascular

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.